A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: an invited review

• Published in: American journal of physiology. Heart and circulatory physiology 2018-06, Vol.314 (6), p.H1117-H1136
• Main Authors: Jorgensen, Dana R, Shaaban, C Elizabeth, Wiley, Clayton A, Gianaros, Peter J, Mettenburg, Joseph, Rosano, Caterina
• Format: Article
• Language: English
• Subjects: Age; Age Factors; Aging; Animals; Biomarkers - metabolism; Biomedical Research - methods; Brain; Cerebral Arteries - diagnostic imaging; Cerebral Arteries - physiopathology; Cerebral Small Vessel Diseases - diagnostic imaging; Cerebral Small Vessel Diseases - epidemiology; Cerebral Small Vessel Diseases - physiopathology; Cerebrovascular Circulation; Cerebrovascular system; Disease control; Etiology; Health risks; Humans; Life span; Literature reviews; Microcirculation; Microvasculature; Microvessels - diagnostic imaging; Microvessels - physiopathology; Nervous system; Neurological disorders; Neurosciences; Neurosciences - methods; Pathogenesis; Population studies; Population Surveillance - methods; Populations; Prognosis; Review; Risk analysis; Risk Factors; Vascular diseases
• ISSN: 0363-6135; 1522-1539; 1522-1539
• DOI: 10.1152/ajpheart.00535.2017

Aging in later life engenders numerous changes to the cerebral microvasculature. Such changes can remain clinically silent but are associated with greater risk for negative health outcomes over time. Knowledge is limited about the pathogenesis, prevention, and treatment of potentially detrimental changes in the cerebral microvasculature that occur with advancing age. In this review, we summarize literature on aging of the cerebral microvasculature, and we propose a conceptual framework to fill existing research gaps and advance future work on this heterogeneous phenomenon. We propose that the major gaps in this area are attributable to an incomplete characterization of cerebrovascular pathology, the populations being studied, and the temporality of exposure to risk factors. Specifically, currently available measures of age-related cerebral microvasculature changes are indirect, primarily related to parenchymal damage rather than direct quantification of small vessel damage, limiting the understanding of cerebral small vessel disease (cSVD) itself. Moreover, studies seldom account for variability in the health-related conditions or interactions with risk factors, which are likely determinants of cSVD pathogenesis. Finally, study designs are predominantly cross-sectional and/or have relied on single time point measures, leaving no clear evidence of time trajectories of risk factors or of change in cerebral microvasculature. We argue that more resources should be invested in 1) developing methodological approaches and basic science models to better understand the pathogenic and etiological nature of age-related brain microvascular diseases and 2) implementing state-of-the-science population study designs that account for the temporal evolution of cerebral microvascular changes in diverse populations across the lifespan.